Autologous dendritic cells and activated cytotoxic T-cells as combination therapy for breast cancer.

MLA

Shevchenko, Julia A., et al. “Autologous Dendritic Cells and Activated Cytotoxic T-Cells as Combination Therapy for Breast Cancer.” Oncology Reports, vol. 43, no. 2, Feb. 2020, pp. 671–80. EBSCOhost, https://doi.org/10.3892/or.2019.7435.

APA

Shevchenko, J. A., Khristin, A. A., Kurilin, V. V., Kuznetsova, M. S., Blinova, D. D., Starostina, N. M., Sidorov, S. V., & Sennikov, S. V. (2020). Autologous dendritic cells and activated cytotoxic T-cells as combination therapy for breast cancer. Oncology Reports, 43(2), 671–680. https://doi.org/10.3892/or.2019.7435

Chicago

Shevchenko, Julia A., Alexander A. Khristin, Vasily V. Kurilin, Maria S. Kuznetsova, Darya D. Blinova, Natalya M. Starostina, Sergey V. Sidorov, and Sergey V. Sennikov. 2020. “Autologous Dendritic Cells and Activated Cytotoxic T-Cells as Combination Therapy for Breast Cancer.” Oncology Reports 43 (2): 671–80. doi:10.3892/or.2019.7435.